Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
Swiss Cancer Institute
University of Washington